Strategy Team


Those who do not understand the big picture are not in a position to make sound decisions. The members of the Flossbach von Storch AG Strategy Team meet in Cologne regularly. Aside from the daily business, our board members, portfolio managers, capital market strategists and analysts discuss the key issues affecting the capital markets. These are central developments which shape the stock market in the long term.

This team is responsible for our investment strategy:

  • Dr Bert Flossbach (Co-Founder and Board Member)
  • Kurt von Storch (Co-Founder and Board Member)
  • Philipp Vorndran (Capital Market Strategist)
  • Prof Thomas Mayer (Founding Director of the Flossbach von Storch Research Institute)
  • Thomas Lehr (Capital Market Strategist)
  • Sven Brouwers (Portfolio Manager – Private and Institutional Mandates)
  • Dr. Tobias Schafföner (Portfolio Manager, Multi Asset)

Information regarding use and limited distribution


Information regarding use and limited distribution

The use of the professional investors' page is only permitted for professional investors. The information provided in this area will be treated confidentially and is only intended for authorised third parties. The obligation to maintain confidentiality does not apply to information that is already generally accessible.

The information provided on the website of Flossbach von Storch Invest S.A. is intended solely for investors in countries where the respective sub-fund / share class is authorised for distribution. The information is not intended for publication or use by any persons or companies in a country where the sub-fund / share class is not authorised for distribution. If documents have been made available in English this does not mean, however, that authorisation has been granted, or an application has been submitted for distribution in English-speaking countries.

In particular the shares of this fund may therefore not be offered for sale or sold within the United States of America (USA), to or on behalf of US citizens, or to or on behalf of US persons residing in the USA. The published documents and the information contained therein may not be distributed in the USA or other countries in which a fund is not authorised for distribution.